Alzheimer’s Disease and Dementia
Cogstate has supported 100+ AD studies and our therapeutic expertise can help your team detect even subtle cognitive changes via sensitive digital tests and expert data quality programs.
Preclinical Alzheimer’s Disease
Cogstate has substantial expertise in preclinical AD digital and rater-administered cognitive assessments to help your team gather reliable data to answer study questions.
Pediatrics & Rare Disease
Cogstate has a group of neuroscience experts with specific therapeutic expertise in pediatric and rare disease that you can leverage to improve signal detection and increase trial efficiencies.
Parkinson’s Disease
Cogstate can help your team gather quality data via sensitive and reliable digital cognitive testing and endpoint data quality programs for the full range of PD symptoms.
Multiple Sclerosis
Cogstate supports MS trials providing highly sensitive and reliable digital cognitive testing and endpoint data quality support for conventional assessments.
Schizophrenia
Cogstate can provide your trial with valid digital assessments that evaluate cognitive domains of relevance to people with schizophrenia while reducing burden
Oncology
Cogstate helps sponsors better evaluate cognitive impairment by providing sensitive, rapid, and reliable computerized digital cognitive assessments.
Cognitive Safety
Cogstate helps sponsors assess cognitive safety in all stages of drug development and across indications via our brief and reliable computerized cognitive testing.
